CNV

The European Commission approved Novartis drug Lucentis as first effective anti-VEGF treatment for myopic choroidal neovascularization

Lucentis® (ranibizumab) is the first licensed therapy to improve vision in patients with visual impairment due to choroidal neovascularization secondary to…

11 years ago

Rabobank and the trade organisations (De Unie, FNV and CNV) reached agreement concerning pruning back the Collective Labour Agreement until the end of 2015

18-4-2013 — /europawire.eu/ — The new Collective Labour Agreement is expected to go into effect on 1 July 2013. The main…

11 years ago